查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1674034

2025年全球结核病诊断市场报告

Tuberculosis Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年结核病诊断市场规模将强劲成长。预计到 2029 年将成长至 32.4 亿美元，复合年增长率为 8.2%。预测期内的成长可归因于政府的大力支持、FDA 对结核病诊断的核准增加、研发 (R&D) 活动的活性化以及抗药性结核病的出现。预测期内的关键趋势包括关注用于结核病诊断的次世代定序(NGS) 平台、产品创新、结核病感染的 T 细胞检测、基于人工智慧 (AI) 的结核病诊断、便携式设备的使用以及政府与製造商的合作。

结核病发病率的上升推动了结核病诊断市场的需求。结核病是一种严重的感染疾病，主要影响肺部，并透过人们咳嗽或打喷嚏时将微小细菌排到空气中而传播。有效的结核病诊断药物对结核病的早期发现和诊断起着重要作用。例如，2023年3月，美国国家公共卫生机构疾病管制与预防中心（CDC）报告称，2022年美国结核病病例数为8,300例，高于2021年的7,874例。结核病患者的增加正在推动结核病诊断市场的成长。

美国食品药物管理局（FDA）对结核病诊断药物的核准不断增加，可能会进一步促进市场成长。例如，2023年3月，英国医疗诊断公司PerkinElmer Oxford Immunotec宣布，已获得FDA核准，使用Allsheng Instruments生产的另外两款细胞分离设备，即Auto-Pure 24和Auto-Pure 20B平台。此外，2022 年 10 月，PerkinElmer Oxford Immunotec 获得 FDA核准使用 T-Cell Select试剂组，以促进经认可的实验室实现体外诊断 (IVD) 中 T-SPOT.TB 检测工作流程的自动化。 T-Cell Select 是一种週边血单核细胞 (PBMC) 分离试剂，它透过以微珠为基础的细胞分离对 PBMC 进行阳性选择，从而简化了 T-SPOT.TB 测试的细胞製备，T-SPOT.TB 测试是一种受国际监管的 ELISPOT IGRA，旨在检测潜伏性结核感染。预计 FDA 对新型结核病诊断核准的批准将加强并推动结核病诊断市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球结核病诊断PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素、限制因素）
  • 最终用途产业分析
  • 全球结核病诊断市场：成长率分析
  • 全球结核病诊断市场表现：规模与成长，2019-2024
  • 全球结核病诊断市场预测：规模与成长，2024-2029 年，2034 年
  • 结核病诊断的全球总目标市场（TAM）

第六章市场区隔

  • 全球结核病诊断市场（依检测类型、表现及预测），2019-2024 年、2024-2029 年、2034 年
  • 放射线检查
  • 核酸检测
  • 细胞激素激素检测
  • 抗药性检测
  • 皮肤测试/结核菌素试验 (TST)
  • 血液/血清检测
  • 涂片显微镜检查
  • 基于细胞培养的测试
  • 其他测试类型
  • 全球结核病诊断市场依疾病阶段、表现及预测，2019-2024 年、2024-2029 年、2034 年
  • 潜伏性结核病
  • 活动性结核病
  • 全球结核病诊断市场（按最终用户、业绩和预测）2019-2024 年、2024-2029 年、2034 年
  • 医院和诊断实验室
  • 医生办公室检查室
  • 参考实验室
  • 学术研究设施
  • 全球结核病诊断市场，按放射学检测类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 胸部X光检查
  • 电脑断层扫描
  • 全球结核病诊断市场按核酸检测类型、效能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 聚合酵素链锁反应（PCR）
  • 核酸增幅检查（NAAT）
  • 全球结核病诊断市场按细胞激素检测类型、表现和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 干扰素-γ释放试验（IGRA）
  • 全球结核病诊断市场按抗药性检测类型、效能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • GeneXpert MTB/RIF
  • 线探针分析
  • 全球结核病诊断市场，皮肤测试/结核菌素试验（TST）细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 结核菌素皮肤试验（TST）
  • 全球结核病诊断市场、血液/血清学检测细分、类型、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 抗体血清学检测
  • 全球结核病诊断市场，依抹片显微镜类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 抗酸细菌（AFB）涂片检查
  • 全球结核病诊断市场细分（按基于细胞培养的测试类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 坚实的媒体文化
  • 液体培养基培养
  • 全球结核病诊断市场，其他检测类型细分，按类型、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 分子检测
  • 先进的成像技术

第七章 区域和国家分析

  • 全球结核病诊断市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球结核病诊断市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 结核病诊断市场：竞争格局
  • 结核病诊断市场：公司简介
    • Beckton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • Qiagen NV Overview, Products and Services, Strategy and Financial Analysis
    • BioMerieux SA Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • PerkinElmer
  • Thermo Fisher Scientific Inc.
  • Creative Diagnostics
  • Lionex GmbH
  • Biocartis
  • Bio-Techne India Private Limited
  • Bio-Rad Laboratories India Pvt.Ltd
  • Zhejiang Di'an Diagnostics Technology Co., Ltd
  • ADICON Clinical Laboratories
  • Guangzhou Kingmed Diagnostics Center Co. Ltd.
  • Kindstar Global
  • OriGene Technologies
  • Siemens AG
  • LumiraDx Limited
  • TestLine Clinical Diagnostics sro

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年结核病诊断市场：提供新机会的国家
  • 2029年结核病诊断市场：细分市场将带来新机会
  • 2029年结核病诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r26008

Tuberculosis diagnostics encompass tools or tests characterized by high sensitivity and specificity in diagnosing TB and monitoring treatment effectiveness. They aim to identify acid-fast bacilli (AFB) in clinical samples and detect tuberculosis.

The tuberculosis diagnostics market comprises various types of tests such as radiographic testing, laboratory testing, nucleic acid testing, cytokine detection testing, drug resistance testing, skin test (TST)/Mantoux test, blood/serology tests, smear microscopy tests, cell culture-based tests, and other methods. Radiographic tests are utilized to identify chest abnormalities indicative of tuberculosis symptoms. These tests focus on diagnosing lesions that can manifest anywhere in the lungs, differing in cavitation, density, size, and shape. These diagnostic methods encompass nucleic acid testing (NAT), skin testing or Mantoux test (TST), blood testing or serology tests, smear microscopy, cultured-based tests, radiography tests, and other approaches. They serve various disease stages such as latent tuberculosis and active tuberculosis. End-users of tuberculosis diagnostics include hospitals, diagnostic laboratories, physician's office laboratories, reference laboratories, academic institutions, and research facilities.

The tuberculosis diagnostics market research report is one of a series of new reports from The Business Research Company that provides tuberculosis diagnostics market statistics, including tuberculosis diagnostics industry global market size, regional shares, competitors with a tuberculosis diagnostics market share, detailed tuberculosis diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the tuberculosis diagnostics industry. This tuberculosis diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tuberculosis diagnostics market size has grown strongly in recent years. It will grow from $2.21 billion in 2024 to $2.36 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to the rise in the incidence of tuberculosis, increased healthcare expenditure, growth in the number of healthcare facilities, and the rise in the adoption of nucleic acid testing.

The tuberculosis diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.24 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to strong government support, the increasing FDA approvals for tuberculosis diagnostics, the increasing research and development (R&D) activities, and the emergence of drug-resistant TB. Major trends in the forecast period include a focus on next-generation sequencing (NGS) platforms for TB diagnostics, product innovations, t-cell tests for TB infection, artificial intelligence (AI)-based tuberculosis diagnostics, use of portable devices, and collaborations between governments and manufacturers.

The increasing incidence of tuberculosis is boosting demand for the tuberculosis diagnostics market. Tuberculosis is a severe infectious disease primarily affecting the lungs and is transmitted through coughing and sneezing, which release tiny germs into the air. Effective tuberculosis diagnostics play a crucial role in early detection and diagnosis of the disease. For example, in March 2023, the Centers for Disease Control and Prevention (CDC), a US-based national public health organization, reported 8,300 cases of tuberculosis (TB) in the United States in 2022, up from 7,874 cases in 2021. This rise in tuberculosis cases is driving growth in the tuberculosis diagnostics market.

The growing number of approvals from the US Food and Drug Administration (FDA) for tuberculosis diagnostics will further bolster market growth. An illustrative instance is the announcement made in March 2023 by PerkinElmer Oxford Immunotec, a UK-based medical diagnostics company, regarding the FDA approval for the use of two additional cell isolation instruments, Auto-Pure 24 and Auto-Pure 20B platforms, manufactured by Allsheng Instruments. Additionally, in October 2022, PerkinElmer Oxford Immunotec received FDA approval for the use of the T-Cell Select reagent kit, facilitating the automation of the T-SPOT.TB test workflow for in vitro diagnostic (IVD) use by certified laboratories. T-Cell Select, a peripheral blood mononuclear cell (PBMC) isolation reagent, employs positive selection of PBMCs with magnetic bead-based cell separation to streamline the preparation of cells for the T-SPOT.TB test-an internationally regulated ELISPOT IGRA designed for detecting latent tuberculosis infection. This influx of FDA approvals for novel tuberculosis diagnostics is anticipated to reinforce and drive the growth of the tuberculosis diagnostics market.

The prevailing trend shaping the tuberculosis diagnostics market is the adoption of technological innovations, with major market players actively integrating advanced technologies to maintain their market standing. Notably, companies are introducing sophisticated point-of-care (POC) diagnostic methods leveraging artificial intelligence (AI) technology. A case in point is the collaboration between Fujifilm, a Japan-based medical imaging device manufacturer, and Qure.ai, a US-based company specializing in AI-enabled medical imaging solutions. In August 2022, they jointly launched an advanced POC diagnostic method utilizing a battery-powered X-ray machine for tuberculosis diagnosis. The integration of artificial intelligence algorithms enhances testing programs, offering ultra-portability, high accuracy, and efficient solutions for point-of-care diagnostics.

A prominent trend in the tuberculosis diagnostics market is the emphasis on product innovations as companies strive to remain competitive and meet evolving consumer needs and preferences. Product innovation plays a pivotal role in generating enthusiasm, driving sales, and increasing brand awareness. Companies in the tuberculosis diagnostics sector are actively focusing on developing new product solutions to fortify their market positions. A noteworthy example is Redcliffe Labs, an India-based technology-empowered diagnostics service provider, which, in February 2023, introduced the BD MAX MDR TB (Tuberculosis) test. This diagnostic test, performed on the BD MAX molecular diagnostic system, enables clinicians to rapidly test for tuberculosis and multidrug resistance as a first-line test. Clinicians use the test to simultaneously detect bacteria causing TB and ascertain whether the bacteria exhibit mutations associated with resistance to two vital first-line drugs, Isoniazid (INH) and Rifampicin (RIF). This focus on product innovation is integral to strengthening companies' positions within the tuberculosis diagnostics market.

In August 2023, Danaher Corporation, a US-based science and technology company, acquired Abcam plc for approximately $24.00 per share, totaling over $5.7 billion. This acquisition aims to bolster Danaher Corporation's position in the life sciences sector by utilizing Abcam plc's extensive portfolio of high-quality reagents and antibodies. This will enhance Danaher's capabilities in scientific research and development, allowing it to better meet the growing demand for advanced biological research tools. Abcam plc, a UK-based biotechnology company, also provides tuberculosis diagnostics.

Major companies operating in the tuberculosis diagnostics market include Beckton, Dickinson and Company, F. Hoffmann-La Roche Ltd, Qiagen N.V, BioMerieux SA, Danaher Corporation, PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Techne India Private Limited, Bio-Rad laboratories India Pvt.Ltd, Zhejiang Di'an Diagnostics Technology Co., Ltd, ADICON Clinical Laboratories, Guangzhou Kingmed Diagnostics Center Co. Ltd., Kindstar Global, OriGene Technologies, Siemens AG, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Bayer AG, Meridian Bioscience, Abbott laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, Agilent technologies Inc, Akonni Biosystems Inc, Epistem Limited, Gen-Probe, Sysmex South Africa (Pty) Ltd., Bio Certica, BixBio

Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2024. The regions covered in the tuberculosis diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tuberculosis diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The tuberculosis diagnostics market includes revenues earned by entities by providing services related to diagnostic laboratory methods, detection of latent infection, detection of drug resistance, and diagnostic laboratory testings. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tuberculosis Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tuberculosis diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tuberculosis diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tuberculosis diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test Type: Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types
  • 2) By Disease Stage: Latent Tuberculosis, Active Tuberculosis
  • 3) By End-User: Hospitals And Diagnostic Laboratories, Physician's Office Laboratories, Reference Laboratories, Academics And Research Facilities
  • Subsegments:
  • 1) By Radiographic Tests: Chest X-rays; CT Scans
  • 2) By Nucleic Acid Testing: Polymerase Chain Reaction (PCR); Nucleic Acid Amplification Tests (NAATs)
  • 3) By Cytokine Detection Tests: Interferon Gamma Release Assays (IGRAs)
  • 4) By Drug Resistance Tests: GeneXpert MTB/RIF; Line Probe Assays
  • 5) By Skin Test or Mantoux Test (TST): Tuberculin Skin Test (TST)
  • 6) By Blood Or Serology Test: Serological Tests for Antibodies
  • 7) By Smear Microscopy Tests: Acid-Fast Bacilli (AFB) Smear Test
  • 8) By Cell Culture-Based Tests: Solid Media Cultures; Liquid Media Cultures
  • 9) By Other Test Types: Molecular Tests; Advanced Imaging Techniques
  • Companies Mentioned: Beckton, Dickinson and Company; F. Hoffmann-La Roche Ltd; Qiagen N.V; BioMerieux SA; Danaher Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tuberculosis Diagnostics Market Characteristics

3. Tuberculosis Diagnostics Market Trends And Strategies

4. Tuberculosis Diagnostics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Tuberculosis Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Tuberculosis Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Tuberculosis Diagnostics Market Growth Rate Analysis
  • 5.4. Global Tuberculosis Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Tuberculosis Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Tuberculosis Diagnostics Total Addressable Market (TAM)

6. Tuberculosis Diagnostics Market Segmentation

  • 6.1. Global Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radiographic Tests
  • Nucleic Acid Testing
  • Cytokine Detection Tests
  • Drug Resistance Tests
  • Skin Test / Mantoux Test (TST)
  • Blood/Serology Test
  • Smear Microscopy Tests
  • Cell Culture-Based Tests
  • Other Test Types
  • 6.2. Global Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Latent Tuberculosis
  • Active Tuberculosis
  • 6.3. Global Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Diagnostic Laboratories
  • Physician's Office Laboratories
  • Reference Laboratories
  • Academics And Research Facilities
  • 6.4. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Radiographic Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chest X-rays
  • CT Scans
  • 6.5. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Nucleic Acid Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction (PCR)
  • Nucleic Acid Amplification Tests (NAATs)
  • 6.6. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Cytokine Detection Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Interferon Gamma Release Assays (IGRAs)
  • 6.7. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Drug Resistance Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • GeneXpert MTB/RIF
  • Line Probe Assays
  • 6.8. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Skin Test / Mantoux Test (TST), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tuberculin Skin Test (TST)
  • 6.9. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Blood/Serology Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Serological Tests for Antibodies
  • 6.10. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Smear Microscopy Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Acid-Fast Bacilli (AFB) Smear Test
  • 6.11. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Cell Culture-Based Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Solid Media Cultures
  • Liquid Media Cultures
  • 6.12. Global Tuberculosis Diagnostics Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Molecular Tests
  • Advanced Imaging Techniques

7. Tuberculosis Diagnostics Market Regional And Country Analysis

  • 7.1. Global Tuberculosis Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Tuberculosis Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tuberculosis Diagnostics Market

  • 8.1. Asia-Pacific Tuberculosis Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tuberculosis Diagnostics Market

  • 9.1. China Tuberculosis Diagnostics Market Overview
  • 9.2. China Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tuberculosis Diagnostics Market

  • 10.1. India Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tuberculosis Diagnostics Market

  • 11.1. Japan Tuberculosis Diagnostics Market Overview
  • 11.2. Japan Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tuberculosis Diagnostics Market

  • 12.1. Australia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tuberculosis Diagnostics Market

  • 13.1. Indonesia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tuberculosis Diagnostics Market

  • 14.1. South Korea Tuberculosis Diagnostics Market Overview
  • 14.2. South Korea Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tuberculosis Diagnostics Market

  • 15.1. Western Europe Tuberculosis Diagnostics Market Overview
  • 15.2. Western Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tuberculosis Diagnostics Market

  • 16.1. UK Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tuberculosis Diagnostics Market

  • 17.1. Germany Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tuberculosis Diagnostics Market

  • 18.1. France Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tuberculosis Diagnostics Market

  • 19.1. Italy Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tuberculosis Diagnostics Market

  • 20.1. Spain Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tuberculosis Diagnostics Market

  • 21.1. Eastern Europe Tuberculosis Diagnostics Market Overview
  • 21.2. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tuberculosis Diagnostics Market

  • 22.1. Russia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tuberculosis Diagnostics Market

  • 23.1. North America Tuberculosis Diagnostics Market Overview
  • 23.2. North America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tuberculosis Diagnostics Market

  • 24.1. USA Tuberculosis Diagnostics Market Overview
  • 24.2. USA Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tuberculosis Diagnostics Market

  • 25.1. Canada Tuberculosis Diagnostics Market Overview
  • 25.2. Canada Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tuberculosis Diagnostics Market

  • 26.1. South America Tuberculosis Diagnostics Market Overview
  • 26.2. South America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tuberculosis Diagnostics Market

  • 27.1. Brazil Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tuberculosis Diagnostics Market

  • 28.1. Middle East Tuberculosis Diagnostics Market Overview
  • 28.2. Middle East Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tuberculosis Diagnostics Market

  • 29.1. Africa Tuberculosis Diagnostics Market Overview
  • 29.2. Africa Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tuberculosis Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Tuberculosis Diagnostics Market Competitive Landscape
  • 30.2. Tuberculosis Diagnostics Market Company Profiles
    • 30.2.1. Beckton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Qiagen N.V Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. BioMerieux SA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Tuberculosis Diagnostics Market Other Major And Innovative Companies

  • 31.1. PerkinElmer
  • 31.2. Thermo Fisher Scientific Inc.
  • 31.3. Creative Diagnostics
  • 31.4. Lionex GmbH
  • 31.5. Biocartis
  • 31.6. Bio-Techne India Private Limited
  • 31.7. Bio-Rad Laboratories India Pvt.Ltd
  • 31.8. Zhejiang Di'an Diagnostics Technology Co., Ltd
  • 31.9. ADICON Clinical Laboratories
  • 31.10. Guangzhou Kingmed Diagnostics Center Co. Ltd.
  • 31.11. Kindstar Global
  • 31.12. OriGene Technologies
  • 31.13. Siemens AG
  • 31.14. LumiraDx Limited
  • 31.15. TestLine Clinical Diagnostics s.r.o.

32. Global Tuberculosis Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tuberculosis Diagnostics Market

34. Recent Developments In The Tuberculosis Diagnostics Market

35. Tuberculosis Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Tuberculosis Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Tuberculosis Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Tuberculosis Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer